Integral Molecular

About:

Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies

Website: https://www.integralmolecular.com/

Top Investors: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Redevelopment Assistance Capital Program (RACP), Government of Pennsylvania

Description:

The objective of Integral Molecular is to create and utilize novel technologies that promote therapy discoveries against challenging protein targets. With more than 20 years of experience focusing on membrane proteins and antibodies, the company's solutions have helped over 400 companies in research, medication discovery, and vaccine development.

Total Funding Amount:

$21.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)integralmolecular.com

Founders:

Benjamin Doranz, Joseph Rucker

Number of Employees:

11-50

Last Funding Date:

2024-10-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai